nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2015, 02, v.34 326-331
融合表达载体pET32a/Trx-EK-MrVIB的构建及在大肠杆菌中表达
基金项目(Foundation): 海南医学院培育基金(HY2013-11);; 海南医学院大学生创新课题(HYCX201327);; 海南省自然科学基金(814291);; 海南医学院引进人才科研启动经费;; 国家高技术研究发展计划(863计划)课题(2014AA093501)共同资助
邮箱(Email):
DOI: 10.13417/j.gab.034.000326
发布时间: 2015-02-25
出版时间: 2015-02-25
移动端阅读
摘要:

人工设计合成芋螺毒素基因Mr VIB来构建表达载体p ET32a/Trx-EK-Mr VIB,将其转化大肠杆菌BL21(DE3)plys S进行诱导表达。菌体经超声破碎后利用Ni-NTA琼脂糖柱进行亲和层析纯化融合蛋白,SDS-PAGE电泳分析融合蛋白表达。结果表明融合表达载体p ET32a/Trx-EK-Mr VIB经PCR扩增和测序鉴定具有正确的开放阅读框。SDS-PAGE电泳显示融合蛋白在大肠杆菌中获得高效可溶性表达,经一步亲和层析获得纯度大于90%的融合芋螺毒素达73.6 mg/L。本文成功构建了融合表达载体p ET32a/Trx-EK-Mr VIB,融合芋螺毒素Trx-EK-Mr VIB在大肠杆菌中获得高效可溶性表达。

Abstract:

Artificial designed conotoxin Mr VIB gene was synthesized to construct expression vector p ET32a/TrxEK-Mr VIB, which was transformed into E. coli BL21(DE3) p Lys S and induced expression by IPTG. Recombinant fusion proteins were purified by affinity chromatography using Ni-NTA agarose column, the expression and purification of fusion proteins to be analyzed by SDS-PAGE. Fusion expression vector p ET32a/Trx-EK-Mr VIB was confirmed correctly by PCR and sequence analysis. The result of SDS-PAGE showed that fusion protein was high effectively expressed in E. coli, which was purified by one-step affinity chromatography and the purity of fusion conotoxin was greater than 90% and its yield was 73.6 mg/L. Fusion expression vector p ET32a/Trx-EK-Mr VIB was successfully constructed, and fusion conotoxin Trx-EK-Mr VIB was high effectively expressed in E. coli.

KeyWords:
参考文献

Bruce C.,Fitches E.C.,Chougule N.,Bell H.A.,and Gatehouse J.A.,2011,Recombinant conotoxin,Tx VIA,produced inyeast has insecticidal activity,Toxicon,58(1):93-100

de Araujo A.D.,Callaghan B.,Nevin S.T.,Daly N.L.,Craik D.J.,Moretta M.,and Alewood P.F.,2011,Total synthesis of theanalgesic conotoxin Mr VIB through selenocysteine-assistedfolding,Angew.Chem.Int.Ed.Engl.,50(29):6527-6529

Gao B.,Zhangsun D.,Hu Y.,Wu Y.,Sheng L.,Fang L.,Wu X.,Yu J.,and Luo S.,2013a,Expression and secretion offunctional recombinant滋O-conotoxin Mr VIB-His-tag inEscherichia coli,Toxicon,72:81-89

Gao B.,Zhangsun D.,Wu Y.,Lin B.,Zhu X.,and Luo S.,2013b,Expression,renaturation and biological activity of recombinant conotoxin Ge XIVAWT,Appl.Microbiol.Biotechnol.,97(3):1223-1230

Gao B.M.,Li B.Z.,Wu Y.,Lin B.,Zhu X.P.,Zhangsun D.T.,andLuo S.L.,2012,Expression,purification and identfication ofrecombinant conotoxin Ge XIVAWT,Zhongguo ShengwuGongcheng Zazhi(China Biotechnology),32(9):34-40(高炳淼,李宝珠,吴勇,林波,朱晓鹏,长孙东亭,罗素兰,2012,重组芋螺毒素Ge XIVAWT的表达,纯化和鉴定,中国生物工程杂志,32(9):34-40)

Gao B.,Peng C.,Zheng X.,Li B.,Zhangsun D.,and Luo S.,2011,Condition optimization for expression of recombinant conotoxin K41,Shengwu Jishu(Biotechnology),21(4):48-51(高炳淼,彭超,郑晓冬,李宝珠,长孙东亭,2011,重组芋螺毒素K41表达条件优化,生物技术,21(4):48-51)

Hernandez-Cuebas L.M.,and White M.M.,2012,Expression of abiologically-active conotoxin Pr IIIE in Escherichia coli,Protein Expr.Purif.,82(1):6-10

Ji W.,Zhang X.,Hu H.,Chen J.,Gao Y.,Liang S.,and An C.,2005,Expression and purification of Huwentoxin-玉in baculovirus system,Protein Expr.Purif.,41(2):454-458

Kumar G.S.,Ramasamy P.,Sikdar S.K.,and Sarma S.P.,2005,Overexpression,purification,and pharmacological activityof a biosynthetically derived conopeptide,Biochem.Biophys.Res.Commun.,335(3):965-972

Lewis R.J.,Dutertre S.,Vetter I.,and Christie M.J.,2012,Conusvenom peptide pharmacology,Pharmacol.Rev.,64(2):259-298

Mc Intosh J.M.,Hasson A.,Spira M.E.,Gray W.R.,Li W.,MarshM.,Hillyard D.R.,and Olivera,B.M.,1995,A new familyof conotoxins that blocks voltage-gated sodium channels,J.Biol.Chem.,270(28):16796-16802

Pi C.,Liu J.,Wang L.,Jiang X.,Liu Y.,Peng C.,Chen S.,andXu A.,2007,Soluble expression,purification and functionalidentification of a disulfide-rich conotoxin derived fromConus litteratus,J.Biotechnol.,128(1):184-193

Prashanth J.R.,Brust A.,Jin A.H.,Alewood P.F.,Dutertre S.,andLewis R.J.,2014,Cone snail venomics:from novel biologyto novel therapeutics,Future Med.Chem.,6(15):1659-1675

Remigio E.A.,and Duda T.F.,Jr.,2008,Evolution of ecologicalspecialization and venom of a predatory marine gastropod,Mol.Ecol.,17(4):1156-1162

Wang L.,Pi C.,Liu J.,Chen S.,Peng C.,Sun D.,Zhou M.,XiangH.,Ren Z.,and Xu A.,2008,Identification and characterization of a novel O-superfamily conotoxin from Conus litteratus,J.Pept.Sci.,14(10):1077-1083

Wilson M.J.,Zhang M.M.,Azam L.,Olivera B.M.,Bulaj G.,andYoshikami D.,2011,Navbeta subunits modulate the inhibition of Nav1.8 by the analgesic gating modifier mu O-conotoxin Mr VIB,J.Pharmacol.Exp.Ther.,338(2):687-693

Xia L.,Zhang F.,Liu Z.,Ma J.,and Yang J.,2013,Expressionand characterization of cecropin XJ,a bioactive antimicrobial peptide from(Bombycidae,Lepidoptera)in Escherichiacoli,Exp.Ther.Med.,5(6):1745-1751

Xia Z.,Chen Y.,Zhu Y.,Wang F.,Xu X.,and Zhan J.,2006,Recombinant omega-conotoxin MVIIA possesses strong analgesic activity,Bio Drugs,20(5):275-281

Yi P.,Li Y.,Zhang M.,Wang Y.,and Ye B.,2014,Progress in thestudies on marine peptide compounds pharmaceutical biotechnology,Yaowu Shengwu Jishu(Pharmaceutical Biotechnology),21(3):264-269(伊鹏,李英新,张萌萌,王颖,叶波平,2014,海洋多肽类化合物研究进展,药物生物技术,21(3):264-269)

Zhan J.,Chen X.,Wang C.,Qiu J.,Ma F.,Wang K.,and Zheng S.,2003,A fusion protein of conotoxin MVIIA and thioredoxinexpressed in Escherichia coli has significant analgesic activity,Biochem.Biophys.Res.Commun.,311(2):495-500

Zhang Y.,Su P.,Liao X.L.,and Huan H.,2013,Advanced in separation and purification of polypeptide technology,Weishengwuxue Zazhi(Journal of Microbiology),33(5):87-91(张亚,苏品,廖晓兰,黄璜,2013,多肽的分离纯化技术研究进展,微生物学杂志,33(5):87-91)

Zorn S.,Leipold E.,Hansel A.,Bulaj G.,Olivera B.M.,Terlau H.,and Heinemann S.H.,2006,The mu O-conotoxin Mr VIA inhibits voltage-gated sodium channels by associating with domain-3,FEBS Lett.,580(5):1360-1364

基本信息:

DOI:10.13417/j.gab.034.000326

中图分类号:Q78

引用信息:

[1]高炳淼,刘云海,彭超,等.融合表达载体pET32a/Trx-EK-MrVIB的构建及在大肠杆菌中表达[J].基因组学与应用生物学,2015,34(02):326-331.DOI:10.13417/j.gab.034.000326.

基金信息:

海南医学院培育基金(HY2013-11);; 海南医学院大学生创新课题(HYCX201327);; 海南省自然科学基金(814291);; 海南医学院引进人才科研启动经费;; 国家高技术研究发展计划(863计划)课题(2014AA093501)共同资助

发布时间:

2015-02-25

出版时间:

2015-02-25

检 索 高级检索